|
This working group has a diverse global membership representing 70 countriesGroup members are based across 6 continents. The vast majority (>80%) of group members are based in LMICs. |
|
|
|
The group draws on knowledge and experience from across a range of sectors and institutionsThis group seeks to involve interested stakeholders representing the entire spectrum of pharmacovigilance activities. The 10 most common types of instituions represented by working group members are shown opposite, however a myriad of additional organisations are represented! |